MedTrace Logo

Ibedrift- A Trial Comparing a New Approach to Musculoskeletal Pain Consisting of Education and Peer Involvement to Treatment as Usual

NCT00741650 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 2097

Last updated 2015-02-26

No results posted yet for this study

Summary

A randomized controlled trial comparing a new approach to musculoskeletal pain consisting of education and peer involvement to treatment as usual. All local government employees in 1-3 Norwegian municipalities will be invited to participate.

Conditions

  • Neck Pain Musculoskeletal
  • Back Pain Lower Back

Interventions

BEHAVIORAL

Information and Peer advisor

Information at work place and recruitment and training of one employee as a peer advisor who help colleagues who experience musculoskeletal pain with reasons to stay active, help with adjustment in the work situation to allow individuals to stay at work.

BEHAVIORAL

Information, peer advisor and fast referral

Information at work place and recruitment and training of one employee as a peer advisor who help colleagues who experience musculoskeletal pain with reasons to stay active, help with adjustment in the work situation to allow individuals to stay at work. In addition, the peer advisor can refer employees who do not improve to a two day educational program that also includes a medical exam and individual counselling. In addition,

Sponsors & Collaborators

  • Sykehuset i Vestfold HF

    collaborator OTHER

  • Helse Sor-Ost

    collaborator OTHER_GOV

  • NORCE Norwegian Research Centre AS

    lead OTHER

Principal Investigators

  • Aage Indahl, Ph.d · The Hospital of Vestfold

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2011-10-31
Completion
2012-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00741650 on ClinicalTrials.gov